| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director
3 companies
Siegall Clay B serves as a President and CEO at IMNM and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 12 buys and 3 sells. Those positions are worth an estimated $1.5M at current prices.
Historically, Siegall Clay B's trades have earned a strong insider score of 77/100 across 12 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +52.9%.
The biggest single holding is STTK (~$1.3M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 62,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | STTK Shattuck Labs, Inc. | Director | Buy | 62,500 | $4.00 | $250,000.00 | +24.4% | +52.2% | - | |
| Mar 27, 2026 | IMNM Immunome, Inc. | President and CEO | Buy | 25,450 | $19.67 | $500,601.50 | +3.8% | -1.1% | - | |
| Dec 30, 2025 | IMNM Immunome Inc. | President and CEO | Buy | 4,729 | $21.15 | $100,018.35 | +0.7% | -8.9% | - | |
| Dec 19, 2025 | IMNM Immunome Inc. | President and CEO | Buy | 7,278 | $20.48 | $149,053.44 | +0.9% | -2.8% | - | |
| Dec 18, 2025 | IMNM Immunome Inc. | President and CEO | Buy | 46,511 | $21.50 | $999,986.50 | +5.8% | +3.4% | - | |
| Mar 26, 2025 | IMNM Immunome Inc. | President and CEO | Buy | 137,100 | $7.29 | $999,459.00 | +20.5% | +25.8% | +187.9% | |
| Jan 31, 2025 | IMNM Immunome Inc. | President and CEO | Buy | 150,000 | $7.75 | $1,162,500.00 | +28.9% | -19.7% | +123.2% | |
| Nov 22, 2024 | IMNM Immunome Inc. | President and CEO | Buy | 100,000 | $9.62 | $962,181.46 | +23.8% | +3.0% | +88.7% | |
| May 21, 2024 | IMNM Immunome Inc. | President and CEO | Buy | 100,000 | $13.88 | $1,388,072.19 | +31.3% | +4.8% | -42.0% | |
| Oct 2, 2023 | IMNM Immunome Inc. | President and CEO | Buy | 169,204 | $5.91 | $999,995.64 | +112.5% | +34.3% | +64.9% |